CONCEPT OF SELECTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR 1 (S1P1R) MODULATION IN AUTOIMMUNE DISEASES

被引：0
|
作者：
Seemayer, C. [1 ]
Bosset, S. [1 ]
Vaclavkova, A. [2 ]
Hennessy, B. [3 ]
Breu, V.
D'Ambrosio, D. [1 ,4 ]
机构：
[1] Actel Pharmaceut Ltd, Global Clin Sci & Epidemiol, Allschwil, Switzerland
[2] Actel Pharmaceut Ltd, Global Drug Safety, Allschwil, Switzerland
[3] Actel Pharmaceut Ltd, Biostat, Clin Dev, Allschwil, Switzerland
[4] Actel Pharmaceut Ltd, Global Business & Sci Affairs, Allschwil, Switzerland
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2016年 / 34卷 / 04期
关键词：
Sphingosine-1-phosphate (S1P); receptor modulator; autoimmune disease;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5:112
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [21] Discovery, design and synthesis of novel potent and selective sphingosine-1-phosphate 4 receptor (S1P4-R) agonists
    Guerrero, Miguel
    Urbano, Mariangela
    Zhao, Jian
    Crisp, Melissa
    Chase, Peter
    Hodder, Peter
    Schaeffer, Marie-Therese
    Brown, Steven
    Rosen, Hugh
    Roberts, Edward
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 537 - 542
  • [22] Mandelamides as novel agonists of sphingosine-1-phosphate 1 (S1P1)
    Zhang, Yanlei
    Cherney, Robert J.
    Shen, Ding Ren
    Yarde, Melissa
    Cvijic, Mary Ellen
    Gillooly, Kathleen
    Taylor, Tracy
    McIntyre, Kim W.
    Marino, Anthony
    Balimane, Praveen
    Saltercid, Luisa
    Barrish, Joel C.
    Carter, Percy H.
    Xie, Jenny
    Dyckman, Alaric J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [23] Ponesimod, a selective sphingosine 1-phosphate (S1P1) receptor modulator for autoimmune diseases: review of clinical pharmacokinetics and drug disposition
    Dash, Ranjeet Prasad
    Rais, Rana
    Srinivas, Nuggehally R.
    XENOBIOTICA, 2018, 48 (05) : 442 - 451
  • [24] Modulation of Chemokines and Allergic Airway Inflammation by Selective Local Sphingosine-1-phosphate Receptor 1 Agonism in Lungs
    Marsolais, David
    Yagi, Saiko
    Kago, Tomoyuki
    Leaf, Nora
    Rosen, Hugh
    MOLECULAR PHARMACOLOGY, 2011, 79 (01) : 61 - 68
  • [25] Role of sphingosine-1-phosphate receptor 1 and sphingosine-1-phosphate receptor 2 in hyperglycemia-induced endothelial cell dysfunction
    Chen, Shuhua
    Yang, Jie
    Xiang, Hong
    Chen, Wei
    Zhong, Hua
    Yang, Guoping
    Fang, Ting
    Deng, Hao
    Yuan, Hong
    Chen, Alex F.
    Lu, Hongwei
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 35 (04) : 1103 - 1108
  • [26] Sphingosine-1-Phosphate Receptor Phosphorylation and its Effects on Autoimmune Neuroinflammation
    Garris, Christopher S.
    Wu, Linfeng
    Sobel, Raymond A.
    Snyder, Michael
    Hla, Timothy T.
    Dorfman, Leslie J.
    Han, May H.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 958 - 958
  • [27] Prolonging Survival of Corneal Transplantation by Selective Sphingosine-1-Phosphate Receptor 1 Agonist
    Gao, Min
    Liu, Yong
    Xiao, Yang
    Han, Gencheng
    Jia, Liang
    Wang, Liqiang
    Lei, Tian
    Huang, Yifei
    PLOS ONE, 2014, 9 (09):
  • [28] The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases
    Mao-Draayer, Yang
    Sarazin, Jeffrey
    Fox, David
    Schiopu, Elena
    CLINICAL IMMUNOLOGY, 2017, 175 : 10 - 15
  • [29] Inhibitors of sphingosine-1-phosphate metabolism (sphingosine kinases and sphingosine-1-phosphate lyase)
    Sanllehi, Pol
    Abad, Jose-Luis
    Casas, Josefina
    Delgado, Antonio
    CHEMISTRY AND PHYSICS OF LIPIDS, 2016, 197 : 69 - 81
  • [30] Modulation of sphingosine-1-phosphate in ulcerative colitis
    Argollo, Marjorie
    Furfaro, Federica
    Gilardi, Daniela
    Roda, Giulia
    Allocca, Mariangela
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (04) : 413 - 420
12345